Sana Biotechnology, Inc. - 10-Q Filing
Sana Biotechnology reports Q3 financial results including R&D and G&A expense breakdowns and contingent consideration liabilities related to Cobalt Biomedicine and Harvard College agreements.
Sana Biotechnology reports Q3 financial results including R&D and G&A expense breakdowns and contingent consideration liabilities related to Cobalt Biomedicine and Harvard College agreements.